FG-2216
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FG-2216, covering 2007-11-06 to 2007-11-06. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin [Phase 2]